Aventis to launch Ketec, an antibiotic in July.

Aventis will launch Ketec (Telythromycin), an oral antibiotic, in the market from July 1 for the first time over the world, which was specifically developed for the treatment of regional acquired respiratory tract infections. Its effect can be expected by a daily one a day dose for 5 day treatment.

Director Kim Myung-hoon of Aventis said "According to the PROTEKT surveillance conducted in 25...